Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan 5;119(1):34-43.
doi: 10.1182/blood-2011-04-347872. Epub 2011 Nov 15.

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007

Graça M Dores  1 , Susan S Devesa, Rochelle E Curtis, Martha S Linet, Lindsay M Morton
Affiliations

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007

Graça M Dores et al. Blood. .

Abstract

Since 2001, the World Health Organization classification for hematopoietic and lymphoid neoplasms has provided a framework for defining acute leukemia (AL) subtypes, although few population-based studies have assessed incidence patterns and patient survival accordingly. We assessed AL incidence rates (IRs), IR ratios (IRRs), and relative survival in the United States (2001-2007) in one of the first population-based, comprehensive assessments. Most subtypes of acute myeloid leukemia (AML) and acute lymphoblastic leukemia/lymphoma (ALL/L) predominated among males, from twice higher incidence of T-cell ALL/L among males than among females (IRR = 2.20) to nearly equal IRs of acute promyelocytic leukemia (APL; IRR = 1.08). Compared with non-Hispanic whites, Hispanics had significantly higher incidence of B-cell ALL/L (IRR = 1.64) and APL (IRR = 1.28); blacks had lower IRs of nearly all AL subtypes. All ALL/L but only some AML subtypes were associated with a bimodal age pattern. Among AML subtypes, survival was highest for APL and AML with inv(16). B-cell ALL/L had more favorable survival than T-cell ALL/L among the young; the converse occurred at older ages. Limitations of cancer registry data must be acknowledged, but the distinct AL incidence and survival patterns based on the World Health Organization classification support biologic diversity that should facilitate etiologic discovery, prognostication, and treatment advances.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age-specific IRs of AML and ALL/L. Age-specific IRs of AML and ALL/L according to sex and race/ethnicity, SEER-17, 2001 to 2007.
Figure 2
Figure 2
Age-specific IRs of AML, ALL/L, and AL. Age-specific IRs of AML, ALL/L, and AL of ambiguous lineage according to subtype, SEER-17, 2001 to 2007.
Figure 3
Figure 3
RS of AML, ALL/L, and AL. RS of AML, ALL/L, and AL of ambiguous lineage according to subtype and age among individuals diagnosed in SEER-17 during 2001 to 2006 and followed through 2007.
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300. - PubMed
    1. Linet MS, Devesa SS, Morgan GJ. The leukemias. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006. pp. 841–871.
    1. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours. Pathology and Genetics of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
    1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th ed) Lyon, France: International Agency for Research on Cancer; 2008.
    1. Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724–3734. - PubMed

Publication types

MeSH terms